STIMOXYGEN LTD

Active Belfast

Manufacture of medical and dental instruments and supplies

2 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and suppliesResearch and experimental development on biotechnology
S

STIMOXYGEN LTD

Manufacture of medical and dental instruments and supplies

Founded 9 Mar 2021 Active Belfast, Northern Ireland 2 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and suppliesResearch and experimental development on biotechnology
Accounts Submitted 24 Dec 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 23 Mar 2026 Next due 22 Mar 2027 11 months remaining
Net assets £749K £845K 2024 year on year
Total assets £750K £680K 2024 year on year
Total Liabilities £1K £166K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O A&L Goodbody Northern Ireland Llp 42-46 Fountain Street Belfast BT1 5EF Northern Ireland

Email

info@example.com

Website

www.example.com

Full company profile for STIMOXYGEN LTD (NI677236), an active life sciences and medical technology company based in Belfast, Northern Ireland. Incorporated 9 Mar 2021. Manufacture of medical and dental instruments and supplies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£696.86k

Increased by £630.86k (+956%)

Net Assets

£749.04k

Increased by £845.33k (+878%)

Total Liabilities

£1.05k

Decreased by £165.71k (-99%)

Turnover

N/A

Employees

2

Debt Ratio

N/A

Decreased by 237 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Mar 2025Venture - Series Unknown

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 60,903 Shares £406.07 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
16 Jan 20252,244£0.224£0
16 Jan 202529,412£2.941£0
16 Jan 20252,238£0.224£0
16 Jan 20251£0£0
16 Jan 202510,121£1.012£0

Officers

Officers

2 active 1 resigned
Status
Russell, Leslie James, DrDirectorBritishUnited Kingdom739 Mar 2021Active
Sarcon Compliance LimitedCorporate-secretaryUnited KingdomUnknown9 Mar 2021Active

Shareholders

Shareholders (15)

Sian Farrell
15.9%
25,600
Innovation Ulster Limitied
14.0%
22,524

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Professor John Callan

Ceased 15 Jan 2025

Ceased

Anthony Mchale

Ceased 15 Jan 2025

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
23 Mar 2026Confirmation StatementConfirmation statement made on 2026-03-08 with no updates
11 Mar 2026OfficersTermination of Samuel Rothstein as director on 2026-02-20
4 Mar 2026AddressChange Registered Office Address Company With Date Old Address New Address
24 Dec 2025AccountsAnnual accounts made up to 2025-03-31
27 Mar 2025AccountsAnnual accounts made up to 2024-03-31
23 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-03-08 with no updates

11 Mar 2026 Officers

Termination of Samuel Rothstein as director on 2026-02-20

4 Mar 2026 Address

Change Registered Office Address Company With Date Old Address New Address

24 Dec 2025 Accounts

Annual accounts made up to 2025-03-31

27 Mar 2025 Accounts

Annual accounts made up to 2024-03-31

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-08 with no updates

1 months ago on 23 Mar 2026

Termination of Samuel Rothstein as director on 2026-02-20

1 months ago on 11 Mar 2026

Change Registered Office Address Company With Date Old Address New Address

1 months ago on 4 Mar 2026

Annual accounts made up to 2025-03-31

4 months ago on 24 Dec 2025

Annual accounts made up to 2024-03-31

1 years ago on 27 Mar 2025